DOI:
10.1055/s-00000175
Arzneimittelforschung
LinksClose Window
References
Dev IK, Dornsife RE, Hopper TM et al.
Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models.
Br J Cancer 2004;
91: 1391-1398
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.